SCALE UP Utah II: Community-Academic Partnership to Address COVID-19 Testing and Vaccination Among Utah Community Health Centers
SCALE UP Utah II:社区学术合作以解决犹他州社区健康中心的 COVID-19 检测和疫苗接种问题
基本信息
- 批准号:10444656
- 负责人:
- 金额:$ 114.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-01 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptedAdoptionAdultAreaCOVID-19COVID-19 pandemic effectsCOVID-19 testingCOVID-19 vaccinationCharacteristicsClinicClinical SciencesCollaborationsCommunitiesCommunity HealthCommunity Health AidesDataData AnalyticsDiagnostic Reagent KitsDiseaseDisease OutbreaksEventGrantHealthHealth SciencesHealthcare SystemsHomeHourHumanIndividualInfrastructureInstitutesInterventionLatinoLatino PopulationNative AmericansNeighborhood Health CenterOutcomePatientsPhasePopulationPopulations at RiskPovertyPrimary Health CareProcessRADx Underserved PopulationsResearchResource-limited settingResourcesRiskRunningRuralRural PopulationSiteSurveysSystemTarget PopulationsTelephoneTestingText MessagingTimeTouch sensationTranslational ResearchUnderserved PopulationUninsuredUniversitiesUtahVaccinatedVaccinationVariantWorkcohortcontextual factorscoronavirus diseasecostdesigndigitalethnic minorityexperienceflexibilityfrontierhealth care settingshealth communicationhealth inequalitieshealth information technologyhealth managementhome testimplementation scienceintervention effectlow socioeconomic statusnoveloutcome predictionoutreachpandemic diseasepatient orientedpatient outreachpopulation healthracial and ethnicrapid testresponsescale uptesting uptakeunvaccinateduptakevaccine acceptance
项目摘要
PROJECT SUMMARY/ABSTRACT
Racial/ethnic minority, low socioeconomic status (SES), and rural populations suffer profound health inequi-
ties across a wide variety of diseases and conditions, as well as a disproportionate burden of the negative health
consequences of the COVID-19 pandemic. As of June 2021, the cumulative COVID case rate in Utah per
100,000 was 10,803 among Whites vs. 17,541 among Latinos. The positivity rate was 14% among Whites vs.
24% among Latinos. Similar disparities persist across the nation regarding vaccination rates between urban vs.
rural, high vs. low SES, and White vs. non-White populations. Low vaccination rates leave underserved popula-
tions at risk for local outbreaks, and more contagious and severe variants. Thus, interventions targeting these
populations at the interplay between testing and vaccination are critical for pandemic control. Not only do un-
derserved populations experience profound health inequities, but there is also a critical digital divide between
high and low resource healthcare systems. Low resource settings are far less likely to adopt Health Information
Technology approaches, and often do not have the capacity to implement large scale population health man-
agement (PHM) efforts utilizing data analytics and automated patient outreach. Community Health Centers
(CHCs) are optimal settings for implementing these PHM interventions to increase the uptake of COVID-19
testing and vaccination among underserved populations. Eleven Utah CHC systems are participating in
SCALE-UP II. Their 38 primary care clinics serve over 112,000 unique underserved patients annually. Sup-
ported by a RADx-UP Phase I grant (SCALE-UP Utah), we have established a flexible text messaging outreach
and patient navigation infrastructure with CHCs to increase testing and vaccine uptake. SCALE-UP II will lev-
erage this infrastructure as well as long standing partnerships among the University of Utah Clinical and
Translational Science Institute, Association for Utah Community Health, CHCs across the entire state, and the
Utah Department of Health. SCALE-UP II will investigate three PHM interventions at the interplay between
COVID-19 vaccination and testing: 1) Text Messaging (TM) – bidirectional text messaging with a one-touch
response to connect patients to vaccination or mail at-home rapid test kits at no cost for use as needed, 2) Con-
versational Agent (CA) – automated, scripted and interactive agent used to mimic human interaction to offer
access to at-home rapid test kits, 3) Patient Navigation (PN) – phone call from a community health worker to
help address hesitancy and access barriers, and to offer at-home rapid test kits. Two types of PN will be tested:
Reactive PN (RPN) will reach out only to those patients who reply YES to a TM/CA message. Proactive PN
(PPN) will reach out to all patients, including those who do not reply to a TM/CA message. The specific aims
are to 1) Conduct a 2 (TM vs. CA) X 3 (No PN vs. RPN vs. PPN) factorial design assessing intervention effects
on testing uptake among unvaccinated adults 2) Examine factors associated with at-home testing and vaccina-
tion uptake over time.
项目摘要/摘要
种族/族裔少数民族,低社会经济地位(SES)和农村人口遭受深远的健康状况
跨多种疾病和疾病的关系,以及不成比例的负面健康状况
19009大流行的后果。截至2021年6月,犹他州的累积共同案例率
在白人中,有100,000是10,803,而拉丁美洲人中的17,541。白人与白人之间的阳性率为14%。
拉丁美洲人中有24%。全国各地的类似差距在城市与城市与疫苗接种率方面持续存在。
乡村,高与低SE,白色与非白人人群。低疫苗接种率留下了未服务的人口
面临当地暴发的风险,以及更具传染性和严重的变体。那是针对这些的干预措施
测试和疫苗接种之间相互作用的种群对于大流行控制至关重要。不仅不
当之无愧的人口经历了深刻的健康不平等,但数字鸿沟也有关键的数字鸿沟
高和低资源保健系统。资源设置低得多的可能采用健康信息
技术方法,通常没有能力实施大规模的人口健康管理
使用数据分析和自动化患者外展的Agement(PHM)努力。社区卫生中心
(CHC)是实施这些PHM干预措施以增加COVID-19的最佳设置
在服务不足的人群中进行测试和疫苗接种。 11个犹他州CHC系统正在参与
扩展II。他们的38个初级保健诊所每年为112,000多名独特的患者服务。 su
在Radx-Up阶段I赠款(犹他州的扩大)上,我们建立了灵活的文本消息外展
以及使用CHC的患者导航基础设施,以增加测试和疫苗的摄取。扩大II将会
在犹他大学临床和
翻译科学研究所,犹他州社区卫生协会,整个州的CHC,以及
犹他州卫生部。扩展II将研究在相互作用的三种PHM干预措施
COVID-19疫苗接种和测试:1)文本消息传递(TM) - 双向文本消息传递
响应将患者连接到疫苗接种或邮寄家庭快速测试套件,无需使用,2)
使用版本代理(CA) - 自动化,脚本和交互式代理,用于模仿人类互动以提供
访问在家快速测试套件,3)患者导航(PN) - 社区卫生工作者的电话
帮助解决犹豫和访问障碍,并提供在家快速测试套件。将测试两种类型的PN:
反应性PN(RPN)只会接触到那些对TM/CA消息回答的患者。主动PN
(PPN)将与所有患者联系,包括那些未回复TM/CA消息的患者。具体目标
到1)进行2(TM与CA)X 3(无PN与RPN与PPN)阶乘设计评估干预效果
在未接种疫苗的成年人中测试摄取2)检查与家庭测试和疫苗相关的因素
随着时间的推移吸收。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GUILHERME DEL FIOL其他文献
GUILHERME DEL FIOL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GUILHERME DEL FIOL', 18)}}的其他基金
GARDE: Scalable Clinical Decision Support for Individualized Cancer Risk Management
GARDE:个性化癌症风险管理的可扩展临床决策支持
- 批准号:
10741231 - 财政年份:2023
- 资助金额:
$ 114.64万 - 项目类别:
SCALE UP Utah II: Community-Academic Partnership to Address COVID-19 Testing and Vaccination Among Utah Community Health Centers
SCALE UP Utah II:社区学术合作以解决犹他州社区健康中心的 COVID-19 检测和疫苗接种问题
- 批准号:
10544764 - 财政年份:2022
- 资助金额:
$ 114.64万 - 项目类别:
Scalable Clinical Decision Support for Individualized Cancer Risk Management
个性化癌症风险管理的可扩展临床决策支持
- 批准号:
10215413 - 财政年份:2017
- 资助金额:
$ 114.64万 - 项目类别:
Scalable Clinical Decision Support for Individualized Cancer Risk Management
个性化癌症风险管理的可扩展临床决策支持
- 批准号:
9979779 - 财政年份:2017
- 资助金额:
$ 114.64万 - 项目类别:
Scalable Clinical Decision Support for Individualized Cancer Risk Management
个性化癌症风险管理的可扩展临床决策支持
- 批准号:
9295773 - 财政年份:2017
- 资助金额:
$ 114.64万 - 项目类别:
Meeting Clinicians' Information Needs with Highly Tailored Knowledge Summaries
通过高度定制的知识摘要满足临床医生的信息需求
- 批准号:
8643820 - 财政年份:2013
- 资助金额:
$ 114.64万 - 项目类别:
Meeting Clinicians' Information Needs with Highly Tailored Knowledge Summaries
通过高度定制的知识摘要满足临床医生的信息需求
- 批准号:
9031148 - 财政年份:2013
- 资助金额:
$ 114.64万 - 项目类别:
Context-Aware Knowledge Delivery into Electronic Health Records
将情境感知知识传递到电子健康记录中
- 批准号:
8118595 - 财政年份:2009
- 资助金额:
$ 114.64万 - 项目类别:
Context-Aware Knowledge Delivery into Electronic Health Records
将情境感知知识传递到电子健康记录中
- 批准号:
8286769 - 财政年份:2009
- 资助金额:
$ 114.64万 - 项目类别:
相似国自然基金
采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
- 批准号:32371047
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
破解老年人数字鸿沟:老年人采用数字技术的决策过程、客观障碍和应对策略
- 批准号:72303205
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
通过抑制流体运动和采用双能谱方法来改进烧蚀速率测量的研究
- 批准号:12305261
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
采用多种稀疏自注意力机制的Transformer隧道衬砌裂缝检测方法研究
- 批准号:62301339
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
政策激励、信息传递与农户屋顶光伏技术采用提升机制研究
- 批准号:72304103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study
道德伤害综合症创新治疗的实施:2 型混合研究
- 批准号:
10752930 - 财政年份:2024
- 资助金额:
$ 114.64万 - 项目类别:
HIV Clinic-based Screening for Geriatric Syndromes in Older Adults with HIV
基于艾滋病毒临床的艾滋病毒感染者老年综合症筛查
- 批准号:
10761940 - 财政年份:2023
- 资助金额:
$ 114.64万 - 项目类别:
Crossroads: Using decision making strategies to develop high impact content for training in rigor and transparency.
十字路口:使用决策策略来开发高影响力的内容,以进行严格和透明的培训。
- 批准号:
10722510 - 财政年份:2023
- 资助金额:
$ 114.64万 - 项目类别:
The impact of Medicaid expansion on the rural mortality penalty in the United States
医疗补助扩大对美国农村死亡率的影响
- 批准号:
10726695 - 财政年份:2023
- 资助金额:
$ 114.64万 - 项目类别:
Dissemination and implementation of DIGEST™ as an evidence-based measurement tool for dysphagia in cancer
传播和实施 DIGEST™ 作为癌症吞咽困难的循证测量工具
- 批准号:
10584824 - 财政年份:2023
- 资助金额:
$ 114.64万 - 项目类别: